Back to Search Start Over

Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study

Authors :
Haomin Yang
Jonas F. Ludvigsson
Emilio Ugalde-Morales
Jingmei Li
Flaminia Chiesa
Kamila Czene
Per Hall
Judith S. Brand
Source :
BMC Medicine, Vol 15, Iss 1, Pp 1-8 (2017), Yang, H, Brand, J S, Li, J, Ludvigsson, J F, Ugalde-Morales, E, Chiesa, F, Hall, P & Czene, K 2017, ' Risk and predictors of psoriasis in patients with breast cancer : a Swedish population-based cohort study ', BMC Medicine, vol. 15, 154 . https://doi.org/10.1186/s12916-017-0915-4, BMC Medicine
Publication Year :
2017
Publisher :
BMC, 2017.

Abstract

BACKGROUND: The risk of psoriasis in patients with breast cancer is largely unknown, as available evidence is limited to case findings. We systematically examined the incidence and risk factors of psoriasis in patients with breast cancer. METHODS: A Swedish nationwide cohort of 56,235 breast cancer patients (2001-2012) was compared to 280,854 matched reference individuals from the general population to estimate the incidence and hazard ratio (HR) of new-onset psoriasis. We also calculated HRs for psoriasis according to treatment, genetic, and lifestyle factors in a regional cohort of 8987 patients. RESULTS: In the nationwide cohort, 599 patients with breast cancer were diagnosed with psoriasis during a median follow-up of 5.1 years compared to 2795 cases in the matched reference individuals. This corresponded to an incidence rate of 1.9/1000 person-years in breast cancer patients vs. 1.7/1000 person-years in matched reference individuals. Breast cancer patients were at an increased risk of psoriasis (HR = 1.17; 95% confidence interval (CI) = 1.07-1.28), especially its most common subtype (psoriasis vulgaris; HR = 1.33; 95% CI = 1.17-1.52). The risk of psoriasis vulgaris was highest shortly after diagnosis but remained increased up to 12 years. Treatment-specific analyses indicated a higher risk of psoriasis in patients treated with radiotherapy (HR = 2.44; 95% CI = 1.44-4.12) and mastectomy (HR = 1.54, 95% CI = 1.03-2.31). Apart from treatment-specific effects, we identified genetic predisposition, obesity, and smoking as independent risk factors for psoriasis in breast cancer patients. CONCLUSIONS: The incidence of psoriasis is slightly elevated among patients with breast cancer, with treatment, lifestyle, and genetic factors defining the individual risk profile.<br />Funding agencies:Swedish Initiative for research on Microdata in the Social and Medical Sciences (SIMSAM) 80748301 China Scholarship Council 201406010275 Ake Wiberg Foundation Ollie och Elof Ericssons Foundation for Scientific Research

Details

Language :
English
ISSN :
17417015 and 20012012
Volume :
15
Issue :
1
Database :
OpenAIRE
Journal :
BMC Medicine
Accession number :
edsair.doi.dedup.....d5f1c47735bff1b0e27b75013d8dbf9d
Full Text :
https://doi.org/10.1186/s12916-017-0915-4